“如果药店不卖药的话,将会是一种悲哀。”在2004年12月18日召开的“金象发展战略高级研讨会”上,中国医药商业协会副会长王锦霞颇为沉重地发表了如上言论。 进入2005年,一直处于北京药品零售业领跑者行列的北京金象敏感地意识到寒流的来临:一向壁垒森严的北京市场对外地企业开禁,中国药品分销业务对国外资本的准入放开,药品分类管理逐步到位处方药将全凭处方销售,国家医疗体制改 “If pharmacies do not sell drugs, it will be a sad thing.” At the “Golden Elephant Development Strategy Advanced Symposium” held on December 18, 2004, Wang Jinxia, ​​vice president of China Pharmaceutical Business Association, was quite He made the remarks heavily. In 2005, Beijing Golden Elephant Co., Ltd., which has been the leader in drug retail industry in Beijing, was sensitively aware of the coming of the cold wave: the Beijing market, which has been heavily guarded, banned foreign enterprises, the access of Chinese pharmaceutical distribution business to foreign capital was liberalized, and the drug classification Management Gradually place prescription drugs will be based entirely on prescription sales, the state health system reform